SCN8A and Alzheimer disease: Considering the advantageous pharmacological profile of short peptides—such as enhanced stability, solubility, and bioavailability via synthetic amino acids engineering67—the GEDC motif emerges as both a pivotal functional element in Tn‐R's EGF‐L domain and a promising molecular template for designing Nav1.6‐directed AD therapeutics.